RNS
PBYI icon

Robert N. Shapiro’s Puma Biotechnology PBYI Stock Holding History

Robert N. Shapiro’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-396
Closed -$41K – 782
2013
Q4 		$41K Buy
+396
New +$23.2K 0.01% 485

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Robert N. Shapiro's PBYI Position: Q1 2014 in Review

Robert N. Shapiro sold out of Puma Biotechnology (PBYI) in Q1 2014, closing a stake of 396 shares — an estimated $41K sold.

Robert N. Shapiro first reported a position in PBYI in Q4 2013 and held it in 1 quarter. The position peaked at $41K in Q4 2013. 138 funds tracked by Wall St. Rank hold PBYI as of Q1 2014.

  • Robert N. Shapiro reported no remaining Puma Biotechnology position as of Q1 2014 after selling out during the quarter.
  • Robert N. Shapiro sold 396 Puma Biotechnology shares in Q1 2014, an estimated $41K.
  • Robert N. Shapiro first reported a position in Puma Biotechnology in Q4 2013 and held it in 1 quarter.
  • Robert N. Shapiro's Puma Biotechnology position peaked at $41K in Q4 2013.
  • 138 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2014.

Based on Robert N. Shapiro's 13F filing for Q1 2014, filed 18 Jun 2014.